Many people do not have symptoms of chronic myeloid leukemia (CML) when they are diagnosed.
They may be diagnosed during a routine check up, or if their family doctor prescribes blood tests for an unrelated issue.
If your doctor suspects CML, further tests will determine if you have the Philadelphia chromosome, or the Bcr-Abl oncogene.
The phase of your CML will also be identified, usually by a bone marrow biopsy.
Knowing all of this information will allow us to use different targeted therapies specific to your type of cancer.
If you were diagnosed at another health care center, and are coming to Penn Medicine’s Abramson Cancer Center for treatment or a second opinion, repeat diagnostic tests may be necessary.
This is because at Penn, we have access to the latest diagnostic imaging tools, tests and procedures to navigate your personalized treatment plan.